Health Catalyst (HCAT) Reiterated at Hold by Stifel: 'Remain on the Sidelines'
Tweet Send to a Friend
Stifel analyst David Grossman reiterated a Hold rating and $3.75 price target on Health Catalyst Inc. (NASDAQ: HCAT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
